Cargando…
Noninvasive monitoring of the genetic evolution of EGFR-mutant non-small-cell lung cancer by analyzing circulating tumor DNA during combination chemotherapy with gefitinib and pemetrexed or S-1
BACKGROUND: Repetitive genotyping is useful to assess the genetic evolution of non-small-cell lung cancer (NSCLC) during treatment, but the need for sampling by biopsy is a major obstacle. Digital polymerase chain reaction (PCR) is a promising procedure for the detection of mutant alleles in plasma...
Autores principales: | Nakahara, Yoshiro, Takagi, Yusuke, Hosomi, Yukio, Kagei, Akiko, Yamamoto, Tomohiro, Sawada, Takeshi, Yomota, Makiko, Okuma, Yusuke, Mikura, Shinichiro, Okamura, Tatsuru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004997/ https://www.ncbi.nlm.nih.gov/pubmed/27601920 http://dx.doi.org/10.2147/OTT.S105976 |
Ejemplares similares
-
Eligibility for Bevacizumab as an Independent Prognostic Factor for Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Cohort Study
por: Takagi, Yusuke, et al.
Publicado: (2013) -
Retrospective analysis of unknown primary cancers with malignant pleural effusion at initial diagnosis
por: Ebata, Takahiro, et al.
Publicado: (2015) -
A single-arm phase II trial of weekly nanoparticle albumin-bound paclitaxel (nab-paclitaxel) monotherapy after standard of chemotherapy for previously treated advanced non-small cell lung cancer
por: Kato, Yasuhiro, et al.
Publicado: (2019) -
Alectinib for choroidal metastasis in a patient with crizotinib-resistant ALK rearranged positive non-small cell lung cancer
por: Okuma, Yusuke, et al.
Publicado: (2015) -
Key components of chemotherapy for thymic malignancies: a systematic review and pooled analysis for anthracycline-, carboplatin- or cisplatin-based chemotherapy
por: Okuma, Yusuke, et al.
Publicado: (2014)